05589504 is referenced by 38 patents and cites 3 patents.

Based on the discovery that the human bilirubin/phenol UDP-glucuronosyltransferase ugt1 gene complex contains an electrophile responsive element and the knowledge that the rat NADP(H):quinone reductase gene contains an electrophile responsive element, agents which at a concentration of less than 50 .mu.M double the quinone reductase specific activity of Hepa 1clc7 cells, e.g., BHT and sulforaphane, are used for the prophylaxis or treatment of newborn jaundice.

Title
Treatment of newborn jaundice
Application Number
8/279899
Publication Number
5589504
Application Date
July 26, 1994
Publication Date
December 31, 1996
Inventor
Jayanta R Chowdhury
New Rochelle
NY, US
Andrew J Dannenberg
New York
NY, US
Assignee
Albert Einstein College of Medicine of Yeshiva University a Division of Yeshiva University
NY, US
Cornell Research Foundation
NY, US
IPC
A61K 31/095
A61K 31/185
A61K 31/195
A61K 31/36
View Original Source